Search Results 31-40 of 17707 for Parkinson's disease
This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...
Health care professionals can't diagnose Parkinson's disease until you have symptoms, which include shaking and slowed movement. But in the research setting, an ...
Projects and studies at Mayo Clinic's Parkinson's Disease & Movement Disorders Lab track disease progression of dementia, yips or golfer's cramp and CTE.
Parkinson's disease is a chronic and progressive neurological condition that affects movement and cognition. While there is still no cure for Parkinson's ...
The Neurobiology of Parkinson's Disease uses elevated alpha-synuclein in patients with brain injuries as a biomarker for diagnosis and prognosis.
An estimated 500,000 Americans suffer from Parkinson's disease, which is characterized by tremor or shakiness, stiffness of the limbs and trunk, slowness of ...
Movement disorders. Signs of Parkinson's disease, known as parkinsonian signs, may occur. These symptoms include slowed movement, rigid muscles, tremor or a ...
Mayo Clinic is launching a young-onset Parkinson's disease clinic to meet the distinct needs of people who have a diagnosis of this neurodegenerative condition ...
Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies the molecular roles underlying neurodegenerative disorders.
Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic study the molecular biology and genes that may drive Parkinson's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.